Table 1.
RA patients (n = 14) | Sample |
CD3+
CD4+ |
CD3+
CD8+ |
CD4+
CD30+ |
CD4+
CD30L+ |
CD8+
CD30+ |
CD8+
CD30L+ |
Treg | Treg CD30+ |
---|---|---|---|---|---|---|---|---|---|
Mean ± S.D. | PB | 73.9 ± 12.5 | 23.8 ± 12.3 | 0.8 ± 0.7 | 2.9 ± 1.8 | 0.1 ± 0.2 | 2.1 ± 0.2 | 5.0 ± 3.8 | 12.5 ± 15.2 |
Mean ± S.D. | SF | 58.0 ± 10.7 | 38.8 ± 11.2 | 8.6 ± 5.6 | 13.9 ± 10.4 | 0.3 ± 0.5 | 2.3 ± 3.2 | 13.8 ± 4.8 | 42.3 ± 14.7 |
| |||||||||
Controls (n = 8) | Sample | CD3+
CD4+ |
CD3+
CD8+ |
CD4+
CD30+ |
CD4+
CD30L+ |
CD8+
CD30+ |
CD8+
CD30L+ |
Treg | Treg CD30+ |
| |||||||||
Mean ± S.D. | PB | 72.3 ± 9.5 | 22.3 ± 10.2 | 0.3 ± 0.5 | 3.2 ± 0.9 | 0.3 ± 0.5 | 1.7 ± 1.7 | 4.5 ± 1.8 | 4.1 ± 4.3 |
Mean ± S.D. | SF | 62.0 ± 7.1 | 33.0 ± 4.2 | 0.5 ± 0.7 | 10.0 ± 1.4 | 0.5 ± 0.7 | 6.9 ± 5.8 | 4.0 ± 2.8 | 19.0 ± 11.3 |